IGF1R and cancer: Deregulation of IGF-1R signalling has been noted to contribute to a variety of diseases including diabetic retinopathy [3], diabetic nephropathy [4], age-related macular degeneration [5], cardiovascular disease, and aging and in a variety of cancers [5].